|Articles|February 11, 2022
- Pharmaceutical Commerce - February 2022
- Volume 17
- Issue 1
Pharmaceutical Commerce - February 2022 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Commerce February 2022 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 4 years ago
A Lowdown on Logisticsalmost 4 years ago
The Shifting Course in Logistics Supportalmost 4 years ago
How 3PLs Can Up Their Pharma Gamealmost 4 years ago
For Industry in Flux, is M&A Jolt in Store?almost 4 years ago
CAR-T Therapies: Three Supply Chain Considerationsalmost 4 years ago
The Risk of Doubling Down on Pharmaalmost 4 years ago
Striving for Authentic, Transparent Track and Tracealmost 4 years ago
2022 Pharma 3PL Service Provider Directoryalmost 4 years ago
Booster Rollout Lessons for Pharmaalmost 4 years ago
Assessing Adoption of Hybrid DtP ModelsNewsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
2
How AI-Powered Precision Is Reshaping Medical Affairs
3
Price Transparency Advances, Prior Authorization Still Stalls
4
Cencora Accelerates Global 3PL Expansion With Major Investments in Cold Chain and Specialty Logistics
5
